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Abstract: Granulomatosis with polyangiitis (GPA) is associated with a broad range of clinical 
manifestations including renal disease. It is a systemic vasculitis that is rarely encountered in 
children. We present a 14-year-old girl who suffered from pharyngitis 1 week before admittance 
to hospital. She was admitted for macroscopic hematuria and oliguria, under the possibility of 
nephritic syndrome. Renal failure with rapidly progressive glomerulonephritis occurred within 
24 hours. Immunologic tests showed the presence of type-C anti-neutrophil cytoplasmic anti-
bodies (c-ANCA with antiproteinase 3 specificity) and renal biopsy revealed pauci-immune 
crescentic focal necrotizing glomerulonephritis. Treatment including methylprednisolone and 
cyclophosphamide intravenous pulses allowed renal recovery after 3 weeks. The clinical, hema-
tological, and biochemical parameters improved substantially, achieving remission. Granulo-
matosis with polyangiitis, although rare in children, should be considered in the above clinical 
scenario. This case underlines that knowledge of renal histology diagnosis and early aggressive 
immunosuppressive therapy are essential for the management of these patients.
Keywords: acute renal failure, vasculitis, crescentic pauci-immune glomerulonephritis-Type-C, 
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Introduction
Granulomatosis with polyangiitis (GPA), formerly called Wegener’s granulomatosis, is 
a rare autoimmune disorder of unknown etiology that is characterized by granuloma-
tous inflammation and antineutrophil cytoplasmatic antibodies (ANCA) associated 
with small vessel vasculitis. ANCA are mainly directed against proteinase 3 (PR3). 
GPA has a broad clinical spectrum that ranges from predominantly granulomatous 
manifestations restricted to the respiratory tract, to severe, life-threatening necrotizing 
vasculitis affecting many organs, with a predilection for lung and kidney involvement. 
The disease mostly affects adults aged 25–50 years and is rare in children.1
The European classification criteria for granulomatosis with polyangiitis requires the 
diagnosis of three of the following six features: 1) abnormal urinalysis; 2) granuloma-
tous inflammation on biopsy; 3) nasal sinus inflammation; 4) subglottic, tracheal, or 
endobronchial stenosis; 5) abnormal chest imaging; and 6) positive ANCA testing.2
Case report
The patient is a 14-year-old girl diagnosed with pharyngitis 1 week before admis-
sion. She was referred to the Dr Humberto Notti Pediatric Hospital for macroscopic 
hematuria accompanied by oliguria, with suspicion of nephritic syndrome. On 
examination, the patient appeared healthy with a body mass index of 22.5 kg/m2, with 





no fever or edema. Her blood pressure was 110/90 mmHg 
(normal blood pressure levels for age, height and sex), with 
dispersed abdominal pain, aching shoulders, and myalgias. 
Family history was not significant and there was no history 
of illicit drugs.
Initial laboratory data were as follows: serum creatinine 3.10 
mg/dL, urea 50 mg/dL, hemoglobin concentration 10.3 g/dL, 
and urinalysis with more than 100 red blood cells, some of 
them dysmorphic without crystals or hyaline cylinders. Nega-
tive 24-hour proteinuria was reported. Laboratory data 12 hours 
after admission into hospital were as follows: serum creatinine 
5.7 mg/dL, urea 85 mg/dL, leukocytes 12,500/µL, platelet 
count 115 × 103/µL, C- reactive protein (CRP) 2.27 mg/dL 
(227.3 mg/L), ferritin 313 ng/mL (6–70 ng/mL), fibrinogen 
476 mg% (200–400 mg%),  potassium 3.4 mEq/L, sodium 
133 mEq/L, chloride 93 mEq/L, calcium 8.59 mg/dL, acid 




 20 mmol/L, 
lactate dehydrogenase 800 U/L, and decreased glomerular 
filtration rate 14.4 mL/m/1.73 m2 by Schwartz formula. Chest 
radiograph with diffuse interstitial infiltrate in both lungs was 
demonstrated. Renal ultrasound showed increased kidney size 
with increased renal parenchymal echogenicity consistent with 
parenchymal disease.
Twenty-four hours after admission, peritoneal dialysis 
was started. The next day, creatinine and uremia continued 
to increase. A percutaneous renal biopsy was performed and 
intravenous steroid pulses at 10 mg/kg/day were begun.
Serology tests demonstrated the presence of positive 
C-ANCA by indirect immunofluorescence with documented 
proteinase 3–specific ANCA (PR3-ANCA). P-ANCA and 
peroxidase-specific antineutrophil cytoplasmic autoantibodies 
(MPO-ANCA) were negative. Rheumatoid factor and C3, C4 
complement levels were normal. Anti-DNA antibody titers 
measured by enzyme-linked immunosorbent assay (ELISA) 
and anti-nuclear antibody (ANA) by immunofluorescence 
were at normal levels. Viral serology (hepatitis B and C, HIV), 
and blood and throat cultures were negative. Anti-streptolysin 
O (ASO) titers were within the normal limits.
Diagnosis of renal involvement was confirmed through 
biopsy. Microscopic optic study in 20 glomeruli revealed 
renal parenchyma with less than 50% glomeruli present-
ing segmental capillary fibrinoid necrosis with neutrophil 
exudate surrounding glomeruli. Tubule interstitial infiltrate 
was also shown (Figure 1). Cellular crescent was seen in 
20% of the glomeruli (Figure 2). Immunofluorescence 
with antibodies against IgG, IgA, IgM, and C3 was nega-
tive for immunoglobulins, and the intensity of immuno-
fluorescence staining was very weak (trace or trace to 1+) 
for C3. The final diagnosis was focal segmental necrotizing 
glomerulonephritis.
To investigate other organs affected with small vessel 
vasculitis, nasal cavity and sinuses computer tomography 
(CT) showed rhinosinusitis signals and inflammatory tissue. 
Chest CT showed bilateral pleural effusion.
Immunosuppressive therapy was started with three 
methylprednisolone pulses, following by cyclophosphamide 
intravenous pulses (each with a dosage of 750 mg/m2 body 
surface) continued at monthly intervals for 12 months. After 
23 days, the patient’s renal function recovered. The early 
normalization of the glomerular filtration rate made plasma 
exchange in the protocol treatment unnecessary.
Further, the remission treatment consisted of a daily dose 
of mycophenolate mofetil 750 mg/m2 in two divided doses 
Figure 1 Renal biopsy specimen showing focal necrotizing glomerulonephritis in 
the patient. 
Notes: Segmental capillary fibrinoid necrosis was present in glomeruli without 
crescents (middle and lower arrows) along with periglomerular and interstitial 
infiltration of mononuclear and neutrophil cells (upper arrow); hematoxylin and 
eosin stain. Original magnification ×400.
Figure 2 Renal biopsy specimen showing mild focal segmental extracapillary 
proliferation (arrow); hematoxylin and eosin stain. 
Note: Original magnification ×200.
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and oral prednisolone (1 mg/kg for 6 weeks) followed by 
slow tapering. She was discharged after 5 weeks. Neither 
symptoms nor signs of vasculitis were seen at the last clinical 
control. Six months after diagnosis, the patient was negative 
for PR3-ANCA.
Discussion
The present report describes the development of clinical 
rapidly progressive glomerulonephritis and histological 
crescentic necrotizing glomerulonephritis in a girl. Crescentic 
glomerulonephritis is classified into three main categories 
on the basis of direct immunofluorescence microscopy. 
Anti-glomerular basement membrane (GBM) crescentic 
glomerulonephritis is characterized by the presence of cir-
culating antibodies to GBM and linear deposition of IgG 
along the GBM; immune complex-mediated crescentic 
glomerulonephritis is characterized by the deposition of 
immune complexes in the glomeruli; while pauci-immune 
crescentic glomerulonephritis presents as focal necrotizing 
glomerulonephritis with little or no glomerular staining for 
immunoglobulins.3
Rapid progressive renal failure was an initial clinical 
diagnosis in this patient who suffered from progressive renal 
impairment in a short period of time. Although immune 
complex-mediated crescentic glomerulonephritis is the most 
common cause of rapidly progressive glomerulonephritis 
in children, we unusually found renal histopathology of 
pauci-immune crescentic glomerulonephritis in this patient. 
These findings are also in contrast to previous case series 
in children showing that immune complex glomerulone-
phritis constitutes the majority of cases with crescentic 
glomerulonephritis.4
Importantly, renal biopsy with indirect immunofluores-
cent staining in the patient allowed the exclusion of anti-
GBM antibody disease in the setting of a pulmonary renal 
syndrome. Approximately three-fourths of patients with 
pauci-immune or ANCA-associated crescentic glomerulone-
phritis have systemic small-vessel vasculitis. Only ANCAs 
directed against PR3 or MPO have been associated with 
primary vasculitic syndromes. C-ANCA directed against 
PR3 is most specific for GPA as we have demonstrated in 
this patient.
However, pulmonary involvement occurred in half of the 
patients and subglottic stenosis is frequently present in pedi-
atric patients at onset; these were not observed in our patient. 
Findings on chest radiography are abnormal in two-thirds of 
adults with GPA. Findings on thin-section sinus CT scans are 
abnormal in more than 90% of adults with GPA.
A similar number would be expected in the pediatric 
population, based on an 83% incidence of sinusitis.5
The clinical features identified in our patient as hema-
turia, slightly raised blood pressure, and the rapid loss of 
renal function suggest glomerulonephritis. In addition, with 
positive serum c-ANCA levels and kidney biopsy show-
ing granulomatous inflammation, diagnosis of GPA can be 
confirmed.
In consideration of the pathogenesis, ANCA has been 
examined extensively ever since the soluble lysosomal 
enzymes myeloperoxidase and proteinase 3 were identified 
as targets. Antibodies to these enzymes activate primed neu-
trophils and cause neutrophil-dependent endothelial injury 
in vitro. However, the pathogenic potential of ANCA against 
proteinase 3, which is mainly found in patients with GPA 
remains unproven. Additionally, a subgroup of patients with 
pauci-immune crescentic glomerulonephritis persistently 
lack cANCA.6
Experimental studies have shown that proteinase-3-
directed autoimmunity involves the complementary peptide 
of proteinase 3, which is encoded by the antisense strand of 
the proteinase 3 gene. Exposure of the immune system to this 
peptide triggers the formation of antibodies that cross-react 
with proteinase 3. DNA sequences complementary to the 
proteinase 3 gene have been identified in microorganisms, 
including Staphylococcus aureus, which supports the role of 
infectious agents as triggers of proteinase 3 autoimmunity 
via molecular mimicry.7,8 Recently, Kain et al reported that 
infection by fimbriated bacteria can trigger cross-reactive 
autoimmunity to a previously characterized ANCA antigen, 
lysosomal membrane protein 2 (LAMP-2), which results in 
the production of autoantibodies that activate neutrophils 
and damage human microvascular endothelium in vitro and 
in vivo, causing pauci-immune focal necrotizing glomeru-
lonephritis,9 even though no infection was demonstrated by 
culture studies in our patient.
Our patient was treated with methylprednisolone and 
cyclophosphamide, which stabilized renal function after 
3 weeks. Plasma exchange was not included in the protocol.
The optimal prescription of plasmapheresis for the treat-
ment of GPA is uncertain. Clinical studies have focused on 
the use of plasma exchange to rescue organ function in rapidly 
progressive glomerulonephritis and lung hemorrhage, based 
on the rationale of removing circulating ANCAs.10 However, 
evidence derived from its use in children is scarce.11,12
Even in light of advances in the understanding of 
pathophysiology and serologic testing, renal biopsy remains 
the mainstay of the diagnosis of crescentic  glomerulonephritis, 
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and early definitive diagnosis of rapid progressive renal 
failure is essential to reverse the progression to end-stage 
kidney disease.
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